Peter Kuhn
About Peter Kuhn
Peter Kuhn is a professor and founder currently working at the University of Southern California, where he has been since 2014. He specializes in transdisciplinary research that integrates engineering and life sciences, and he serves as the Director of the USC Michelson Center Convergent Science Institute in Cancer.
Work at Epic Sciences
Peter Kuhn serves as the Founder of Epic Sciences, a role he has held since 2008. His leadership has been pivotal in advancing the company's mission to improve cancer diagnostics and treatment through innovative technologies. Epic Sciences focuses on developing solutions that enhance the understanding of cancer biology and patient care.
Current Role at University of Southern California
Since 2014, Peter Kuhn has been a Professor at the University of Southern California (USC) in Los Angeles. His work involves transdisciplinary research that integrates engineering and life sciences. He is also the Director of the CSI-Cancer at USC Michelson Center, a position he has held since 2019, where he leads initiatives aimed at transforming cancer research and treatment.
Previous Experience at Microsoft and The Scripps Research Institute
Peter Kuhn worked at Microsoft from 2008 to 2012 as a Healthcare Ambassador and Regional Director. His role involved promoting healthcare innovations within the company. Prior to that, he was a Professor at The Scripps Research Institute from 2002 to 2014, where he contributed to significant advancements in biomedical research.
Education and Expertise
Peter Kuhn studied Physics at The Julius Maximilians University of Würzburg, achieving a Vordiplom from 1989 to 1992. He later earned his PhD in Physics from the University at Albany, SUNY, from 1992 to 1995. His academic background supports his expertise in structure-based drug discovery and high-throughput biophysical approaches, which he applies in his research.
Research Interests and Contributions
Peter Kuhn's research interests include effective healthcare solutions for low and middle-income countries. He focuses on leveraging physical and life sciences to enhance medical practices and improve patient outcomes. His work on human performance optimization aims to advance treatment effectiveness and overall quality of life.